CYTALUX Dose Extension Study

Clinical trial NCT07469202 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07469202
Sponsor: On Target Laboratories, LLC
Status: NOT_YET_RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Cancer in the Lung Ovarian Cancer

Start date: 2026-08-15
Primary completion: 2027-02-28
Enrollment: 106

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.